New Concepts in Glaucoma » Program AGRCS2020

Program AGRCS2020

To see some of the highlights of AGRCS2020 Online please visit our AGRCS2020 Online Video Archive, browse through our program, meet our amazing faculty or download the programbook.

Thursday, October 1, 2020 14:00-18:00h CEST
The Science of Glaucoma and Molecular Pathophysiology
14:00-15:20	Session 1
14:00-14:10	Introduction John Samples & Ernst Tamm & Simon Bakker
14:10-14:30	The trabecular meshwork and the impairment of outflow Ernst Tamm
14:30-14:50	Genetics of outflow Mary Wirtz
14:50-15:10	Outflow, collector channels and distal outflow Murray Johnstone
15:10-15:20	Discussion Moderator: John Samples
15:20-15:30	Break
15:30-16:40	Session 2
15:30-15:50	Trabecular intercellular communication Kate Keller
15:50-16:10	Studies in zonal perfusion of the TM: What influences it Janice Vranka
16:10-16:30	Development of the meshwork: What is the embryologic origin and what are the clinical implications, the mesodermal dysgenesis syndromes Ernst Tamm
16:30-16:40	Discussion Moderator: John Samples
16:40-16:50	Break
16:50-18:00	Session 3
16:50-17:10	Mitochondria and glaucomatous neurodegeneration Miriam Kolko
17:10-17:30	Exfoliation Ursula Schlötzer-Schrehardt
17:30-17:50	IOP homeostatic mechanisms Dan Stamer
17:50-18:00	Discussion Moderator: Ernst Tamm

Friday, October 2, 2020 13:40-18:20h CEST
The Science of Intraocular Pressure
13:40-15:20	Session 4
13:40-13:50	Introduction John Samples, Ernst Tamm , Simon Bakker
13:50-14:10	The inner wall of Schlemm’s canal in glaucoma Mark Johnson
14:10-14:30	Ocular rigidity and glaucoma Cynthia Roberts
14:30-14:50	Outflow resistance distal to Schlemm’s Dan Stamer
14:50-15:10	The subtleties of the narrow angle Shan Lin
15:10-15:20	Discussion Moderator: Ernst Tamm
15:20-15:50	Break
15:50-16:40	Session 5
15:50-16:10	OCT angiography and glaucoma David Huang
16:10-16:30	Continuous IOP monitoring Kaweh Mansouri
16:30-16:40	Discussion Moderator: John Samples
16:40-16:50	Break
16:50-18:20	Session 6
16:50-17:10	The value of OCT and perils of interpretations Hans Lemij
17:10-17:30	Glaucoma and intracranial pressure Ingrida Januleviciene
17:30-17:50	How can we measure neuroprotection now and in the future? Andrew Tatham
17:50-18:10	Corticosteroid induced glaucoma Dan Stamer
18:10-18:20	Discussion Moderator: John Samples

Saturday, October 3, 2020 13:00-18:00h CEST
Medications & Lasers
13:00-14:40	Session 7
13:00-13:10	Introduction John Samples, Ernst Tamm , Simon Bakker
13:10-13:30	Methods of modulating outflow resistance Nils Loewen
13:30-13:50	Glaucoma medications Norbert Pfeiffer
13:50-14:10	Clinical advances with rho kinase inhibitors Casey Kopczynski
14:10-14:30	New classes and treatments John Samples
14:30-14:40	Discussion Moderator: TBA
14:40-14:50	Break
14:50-15:10	Session 8
14:50-15:10	Therapeutic effects of Niacin and other nutritional remedies Miriam Kolko
15.10-15.30	Decision to do glaucoma surgery Ike Ahmed
15.30-15.50	Laser trabeculoplasty clinical parameters John Samples
15.50-16.10	How does trabeculoplasty work? Giorgio Dorin
16.10-16.20	Discussion Moderator: Shan Lin
16.20-16.30	Break
16:10-18:00	Session 9
16.30-16.50	Future developments for the use of laser in glaucoma treatment Giorgio Dorin
16.50-17.10	Cyclophotocoagulation Shan Lin
17:10-17:30	Outflow resistance proximal and distal from Schlemm’s canal as it relates to surgery Nils Loewen
17:30-17:50	Trabeculectomy within the spectrum of other filtration procedures Franz Grehn
17:50-18:00	Discussion Moderator: John Samples

Sunday, October 4, 2020 13:00-18:20h CEST
Glaucoma Surgery
13:00-14:00	Session 10
13:00-13:10	Introduction John Samples & Ernst Tamm
13.10-13.30	Types of MIGS, pros and cons of each Ike Ahmed
13.30-13.50	Anatomical considerations for MIGS Nils Loewen
13.50-14.00	Discussion Moderator: John Samples
14.00-14.30	Break
14.30-15.20	Session 11
14.30-14.50	Specifications for glaucoma surgical studies Tony Fea
14.50-15.10	Canal based surgery Nils Loewen
15.10-15.20	Discussion Moderator: TBA
15.20-15.30	Break
15.30-16.40	Session 12
15.30-15.50	The future of glaucoma therapy: tubes and shunts Esther Hoffmann
15.50-16.10	Suprachoroidal Shunts Steven Vold
16.10-16.30	XEN: past and present Vanessa Vera
16.30-16.40	Discussion Moderator: John Samples
16.40-16.50	Break
16.50 18.20	Session 13
16.50 17.10	GATT Ron Fellman
17.10 17.30	The future of glaucoma therapy: pressure Dan Stamer
17.30 17.50	The future of glaucoma therapy: surgery Hagen Thieme
17.50 18.10	The future of glaucoma therapy: summary Ernst Tamm
18.10 18.20	Discussion Moderator: Ernst Tamm

All time are Central European Summer Time (CEST; the time in Amsterdam, The Netherlands).
Convert to your local time here

Improve your ability to treat glaucoma based on new research findings, drug and device development(s).
Introduce newest techniques, how it could affect previous best practices
Identify newest research and future directions
Updates on MIGS
Updates on newest and pipeline drugs and their underlying modes of action
Learn about the newest, often unpublished trabecular meshwork, optic nerve, uveal scleral & other outflow research
Discuss the implications of this new research on Glaucoma drug and device development
Promote increased opportunities for collaborative scientific research and publications, provide a collegial environment and encourage new investigators